14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
May 24, 2018 $15.60 $15.85 $15.30 $15.55 1 107 725
May 23, 2018 $15.00 $15.58 $15.00 $15.50 453 902
May 22, 2018 $15.20 $15.35 $14.85 $15.05 753 962
May 21, 2018 $15.40 $16.05 $15.00 $15.10 1 879 709
May 18, 2018 $14.55 $15.30 $14.35 $15.20 1 066 377
May 17, 2018 $15.00 $15.15 $14.40 $14.55 877 368
May 16, 2018 $15.15 $15.20 $14.80 $15.05 1 166 648
May 15, 2018 $15.20 $15.30 $14.75 $15.15 471 219
May 14, 2018 $14.65 $15.25 $14.65 $15.15 789 281
May 11, 2018 $14.40 $14.85 $13.90 $14.60 898 839
May 10, 2018 $14.60 $14.90 $14.25 $14.43 891 604
May 09, 2018 $13.50 $14.75 $12.53 $14.70 1 573 029
May 08, 2018 $13.35 $14.15 $13.35 $14.00 1 194 683
May 07, 2018 $13.25 $13.50 $13.10 $13.50 887 965
May 04, 2018 $13.25 $13.70 $13.08 $13.25 1 153 641
May 03, 2018 $13.90 $14.11 $13.20 $13.25 697 065
May 02, 2018 $14.25 $14.40 $13.90 $13.95 623 397
May 01, 2018 $14.20 $14.35 $13.95 $14.20 511 542
Apr 30, 2018 $14.50 $14.75 $14.20 $14.20 565 175
Apr 27, 2018 $14.05 $14.60 $14.00 $14.50 723 296
Apr 26, 2018 $13.20 $14.20 $13.10 $14.10 665 395
Apr 25, 2018 $13.15 $13.50 $12.85 $13.20 1 116 642
Apr 24, 2018 $13.65 $13.88 $13.00 $13.05 969 550
Apr 23, 2018 $13.70 $13.95 $13.35 $13.65 762 210
Apr 20, 2018 $14.10 $14.30 $13.65 $13.75 655 695
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT